Navigation Links
SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
Date:3/25/2013

BRISBANE, Calif., March 25, 2013 /PRNewswire/ -- SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a global specialty biopharmaceutical company focused on enabling people with life-altering conditions to lead better lives.  SARcode's lead program, lifitegrast ophthalmic solution, is currently in Phase 3 studies for the treatment of signs and symptoms of dry eye.

"We are extremely pleased to have found a like-minded and visionary partner in Shire," commented Quinton Oswald , CEO of SARcode Bioscience. "They recognize the significant unmet need that exists in dry eye disease, and the great opportunity to provide lifitegrast to millions of dry eye sufferers in the US. Their expertise, particularly in specialty markets, coupled with their global presence and clinical support, will be a tremendous asset to the approval and ultimate commercialization of lifitegrast worldwide."  The SARcode team will remain in place to support the ongoing clinical and manufacturing programs through submission of the New Drug Application to the FDA. 

Under the terms of agreement, Shire will make an upfront payment of $160 million and SARcode shareholders will be eligible to receive additional significant undisclosed payments upon achievement of certain clinical, regulatory, and/or commercial milestones. The transaction is expected to close in the second quarter, subject to regulatory approval in the United States, and other customary closing conditions. 

"The acquisition by Shire validates the need for therapies designed specifically for dry eye, and also underscores the incredible growth prospect in eyecare," commented Robert Alexander , PhD, Director, Alta Partners . "Based upon the positive clinical and regulatory
'/>"/>

SOURCE SARcode Bioscience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
2. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
3. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
6. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
7. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
8. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
9. Dr. Mickey Urdea Joins Pressure BioSciences Board of Directors
10. Dr. Susan Froshauer to join Connecticut bioscience team at CURE
11. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... , March 30, 2015  Check-Cap Ltd. (NASDAQ: ... focused on the development of a preparation-free ingestible imaging ... colorectal cancer, announced today that its CEO, Guy Neev ... 31, 2015 trading day.  Neev and Check-Cap will participate ... the company,s initial public offering and simultaneous private placement ...
(Date:3/30/2015)... March 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ... shareholders have voted at the special meeting of ... previously announced agreement and plan of merger between ... with the outcome of today,s special meetings, and ... for approving the merger agreement," said Rob ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... Pa., May 25, 2011 A study titled ... published in the May 26 issue of ... prostate cancer who have received prior chemotherapy containing ... when treated with ZYTIGA ™ (abiraterone acetate) ...
... (NASDAQ: ITMN ) will outline the company,s corporate ... ongoing plans to commercialize Esbriet ® (pirfenidone) in Europe, ... pirfenidone study, during a meeting with analysts in New York ... the presentations beginning at 8:30 a.m. EDT.   ...
Cached Medicine Technology:Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 2InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 3InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 4InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 5InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 6
(Date:3/30/2015)... (PRWEB) March 30, 2015 Wimbledon Health ... vascular, echocardiogram and NCV testing, ... affiliated physicians in observance of National Doctor’s Day. ... around our office, but on this day, we like ... important role they play in healing patients, promoting overall ...
(Date:3/30/2015)... March 30, 2015 Zane Benefits, ... small businesses, announced its latest webinar "Can Tax-Free ... webcast. This discussion was conducted by Zane ... Zane Benefits, there is a massive transition to ... of selecting a group health plan, employers are ...
(Date:3/30/2015)... Southern Med Law, a law firm representing victims ... a Mirena IUD lawsuit on behalf of ... birth in 2012. The complaint, which is currently pending ... IUD failed to prevent pregnancy due to problems locating ... remove. The inability to remove the IUD from her ...
(Date:3/30/2015)... 2015 The fertility team at ... frequently asked questions to give intended parents across the ... donation. , After unveiling the most affordable, ... the IVF clinic has witnessed an increase in fertility ... center provides attentive reproductive care — with all-inclusive IVF ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 On March 11, ... to Blast Away Fat,” details six new treatment options for ... injections and one is a topical product. The other three ... and Liposonix ) or freezing cold ( CoolSculpting ) ... many options now available to us to permanently remove unwanted ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Recognizes National Doctors’ Day 2Health News:Zane Benefits New Webinar Premium Reimbursement Webinar Now Available On-Demand 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2
... a stir worldwide with US President George Bush getting in ... the process of developing a vaccine to combat the same. ... international organizations met in Washington on Thursday to discuss ways ... the World Health Organization (WHO) have raised the specter of ...
... may expect your partner to inform you of his/her HIV ... a legal stand on this. Even horrifying is the fact ... to protect you // from the virus., ,The Wellington ... against Justin Dalley, who was charged with criminal nuisance after ...
... a London based leading drug company, GlaxoSmithKline for having ... the U.S. Food and Drug Administration two years ago ... This became evident last November when The FDA identified ... ,The Public Citizen Group has registered a case ...
... Diabetes mellitus is an independent risk factor for cardiovascular ... risk by 2-6 fold relative to nondiabetic subjects and ... mellitus patients will die of an atherosclerotic event. In ... cardiovascular disease, and so the presence of even borderline-high-risk ...
... and his colleagues from Southampton University have found a new ... of two or more genes fuse. The research team is ... common form of childhood leukemia, which is called as Acute ... to develop this genetic test. The treatment is given by ...
... the most common forms of dementia among older people, which ... control thought, memory, and language. // , ,Researchers from ... several vitamins and have speculated about their use as preventive ... or above the RDA (400 ìg/d) is associated with a ...
Cached Medicine News:Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:FDA Mislead On Asthma Drug By GlaxoSmithKline 2
Inquire...
... motor-driven internal calibration mass for ... capable of Fully Automatic Self-Calibration ... temperature changes are detected, or ... Built-in RS232 Interface, Shimadzu WindowsDirect ...
... balance. Built-in, motor-driven internal calibration mass ... Automatic Self-Calibration when temperature change detected ... Menu-selected weighing parameters, plug-in peripherals, and ... make this balance series highly accurate ...
60 month warranty; Internal Calibration Mass System Diagnostic to alert operator of abnormal weighing conditions; built-in motorized calibration weight enabling automatic self calibration....
Medicine Products: